Relmada Therapeutics to participate at Wells Fargo 21st Healthcare Conference
Relmada Therapeutics said senior management will participate in the Wells Fargo 21st Annual Healthcare Conference.
CORAL GABLES, Fla., Sept.
01, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced that senior management will particip…